Arquer Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- Arquer Diagnostics's estimated annual revenue is currently $1.3M per year.
- Arquer Diagnostics's estimated revenue per employee is $251,000
Employee Data
- Arquer Diagnostics has 5 Employees.
- Arquer Diagnostics grew their employee count by -55% last year.
Arquer Diagnostics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | Office Manager | Reveal Email/Phone |
3 | Assay Development Scientist | Reveal Email/Phone |
4 | Assay Development Scientist | Reveal Email/Phone |
Arquer Diagnostics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Arquer Diagnostics?
Arquer Diagnostics is a private, UK based diagnostics company focused on the development and commercialisation of a non-invasive diagnostic test for bladder and prostate cancer. The test, which is based on a standard ELISA assay format, can measure in urine a protein directly involved in cell replication. The technology can be easily applied to standard lab practices or automated platforms, and has the potential to be developed into a point of care test. It also has applications beyond prostate and bladder cancer including diagnostics for multiple cancers of the urinogenitary tract, and colorectal and cervical cancer.
keywords:N/AN/A
Total Funding
5
Number of Employees
$1.3M
Revenue (est)
-55%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 10 | N/A | N/A |
#2 | $1M | 11 | N/A | N/A |
#3 | $3.7M | 19 | N/A | N/A |
#4 | N/A | 27 | 8% | N/A |
#5 | $7.2M | 31 | 7% | N/A |